目的为药品行政处罚信息公开制度建设提供合理化建议。方法从法理上分析了行政信息公开与公众利益的相关程度,是否涉及国家秘密、商业秘密、个人隐私以及信息公开的成本等标准,以区分药品行政处罚信息的具体公开范围。结果与结论建议采取逐步实施、适度灵活、科学分类、定期简报等药品行政处罚的信息公开策略。 Objective To provide rationalized proposals for the establishment of an open system of administrative information on drugs. Methods From the jurisprudence analysis of the public information disclosure and public interest, whether it involves state secrets, trade secrets, personal privacy and the cost of information disclosure standards to distinguish the specific scope of the administrative information disclosure of drugs. Results and Conclusion It is suggested to adopt an information disclosure strategy of drug administrative penalties such as gradual implementation, moderate flexibility, scientific classification and regular briefing.